337
Participants
Start Date
October 31, 2005
Primary Completion Date
July 31, 2006
Study Completion Date
July 31, 2006
Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)
A monovalent subvirion H5N1 vaccine (HA of A/Vietnam/1203/04) provided in unit¿¿dose vials containing either 30-mcg/mL A/H5N1 HA or 90-mcg/mL A/H5N1 HA. Subjects will receive 1 of 4 dose levels of vaccine (7.5, 15, 45, or 90 mcg) administered intramuscularly.
University of Maryland Baltimore, Baltimore
UCLA Center For Vaccine Research, Torrance
University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases, Rochester
National Institute of Allergy and Infectious Diseases (NIAID)
NIH